Renaissance Technologies
SRTS icon

Renaissance Technologies’s Sensus Healthcare SRTS Stock Holding History

Renaissance Technologies’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$732K Sell
242,334
-9,900
-4% -$34.7K ﹤0.01% 2451
2026
Q1 		$1M Sell
252,234
-4,800
-2% -$21.3K ﹤0.01% 2277
2025
Q4 		$1.02M Sell
257,034
-4,100
-2% -$15.2K ﹤0.01% 2266
2025
Q3 		$820K Buy
261,134
+11,000
+4% +$43.2K ﹤0.01% 2582
2025
Q2 		$1.19M Sell
250,134
-9,500
-4% -$44.5K ﹤0.01% 2413
2025
Q1 		$1.23M Sell
259,634
-171,300
-40% -$997K ﹤0.01% 2276
2024
Q4 		$2.98M Buy
430,934
+21,600
+5% +$158K ﹤0.01% 1784
2024
Q3 		$2.37M Buy
409,334
+17,800
+5% +$108K ﹤0.01% 1901
2024
Q2 		$2.09M Buy
391,534
+100,294
+34% +$461K ﹤0.01% 1861
2024
Q1 		$1.11M Buy
291,240
+492
+0.2% +$1.78K ﹤0.01% 2427
2023
Q4 		$686K Sell
290,748
-41,525
-12% -$97.2K ﹤0.01% 2615
2023
Q3 		$920K Sell
332,273
-35,661
-10% -$109K ﹤0.01% 2363
2023
Q2 		$1.16M Buy
367,934
+91,800
+33% +$332K ﹤0.01% 2381
2023
Q1 		$1.44M Buy
276,134
+97,400
+54% +$699K ﹤0.01% 2230
2022
Q4 		$1.33M Sell
178,734
-87,300
-33% -$787K ﹤0.01% 2358
2022
Q3 		$3.33M Buy
266,034
+52,600
+25% +$628K ﹤0.01% 1697
2022
Q2 		$1.64M Sell
213,434
-98,700
-32% -$829K ﹤0.01% 2342
2022
Q1 		$3.16M Buy
312,134
+150,200
+93% +$1.37M ﹤0.01% 1885
2021
Q4 		$1.17M Buy
161,934
+139,900
+635% +$766K ﹤0.01% 2532
2021
Q3 		$79K Buy
22,034
+200
+0.9% +$731 ﹤0.01% 3349
2021
Q2 		$84K Buy
21,834
+300
+1% +$1.13K ﹤0.01% 3374
2021
Q1 		$82K Buy
21,534
+3,100
+17% +$12.7K ﹤0.01% 3232
2020
Q4 		$71K Buy
18,434
+5,800
+46% +$17.7K ﹤0.01% 3298
2020
Q3 		$32K Buy
12,634
+1,400
+12% +$3.94K ﹤0.01% 3305
2020
Q2 		$34K Buy
+11,234
New +$29.3K ﹤0.01% 3360
2018
Q4 		– Sell
-48,100
Closed -$403K – 3602
2018
Q3 		$403K Buy
48,100
+20,612
+75% +$149K ﹤0.01% 2920
2018
Q2 		$200K Buy
27,488
+16,088
+141% +$105K ﹤0.01% 3076
2018
Q1 		$67K Buy
11,400
+1,100
+11% +$6.21K ﹤0.01% 3290
2017
Q4 		$53K Sell
10,300
-16,739
-62% -$90.7K ﹤0.01% 3259
2017
Q3 		$135K Buy
+27,039
New +$133K ﹤0.01% 3063

Other funds holding SRTS

PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $551M AUM 49.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
GWM
Greenline Wealth Management Boca Raton, Florida $122M AUM
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Renaissance Technologies's SRTS Position: Q2 2026 in Review

Renaissance Technologies reduced its Sensus Healthcare (SRTS) stake by 3.9% in Q2 2026, selling an estimated $34.7K and leaving 242,334 shares worth $732K. The position accounts for ﹤0.01% of the portfolio, ranked #2451.

Renaissance Technologies first reported a position in SRTS in Q3 2017 and has held it in 30 quarters since. The position peaked at $3.33M in Q3 2022. 38 funds tracked by Wall St. Rank hold SRTS as of Q2 2026.

  • Renaissance Technologies held 242,334 shares of Sensus Healthcare worth $732K as of Q2 2026.
  • Renaissance Technologies sold 9,900 Sensus Healthcare shares in Q2 2026, an estimated $34.7K.
  • Sensus Healthcare made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2451 holding.
  • Renaissance Technologies first reported a position in Sensus Healthcare in Q3 2017 and has held it in 30 quarters since.
  • Renaissance Technologies's Sensus Healthcare position peaked at $3.33M in Q3 2022.
  • 38 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.